Jason Carroll

Jason Carroll

Fortuna: 9 M $ al 31/05/2026

Consumer Services
Health Technology
Consumer Non-Durables

Perfil

Jason Carroll is currently Chief Executive Officer at Tryp Therapeutics, Inc. since 2023, Chief Executive Officer, Director & MD at Entropy Neurodynamics Ltd. since 2024, and Non-Executive Chairman at Island Pharmaceuticals Ltd. starting in 2025.
Formerly, Mr. Carroll was Managing Director at Inova Pharmaceuticals (Philippines), Inc. from 2017 to 2023,.
Managing Director at Johnson & Johnson (Vietnam) Co. Ltd. from 2014 to 2017, and General Manager at Janssen Pharmaceutica (Philippines) from 2012 to 2014.
Education includes undergraduate studies at Flinders University and an MBA from Deakin University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
03/12/2025 32.074.930 ( 10,84 % ) 9 M $ 31/05/2026

Cargos activos de Jason Carroll

EmpresasCargoInicio
ISLAND PHARMACEUTICALS LIMITED Presidente 02/07/2025
Director Ejecutivo 01/10/2023

Antiguos cargos conocidos de Jason Carroll.

EmpresasCargoFin
Corporate Officer/Principal 01/03/2017
Ver el detalle de la experiencia de Jason Carroll.

Formación de Jason Carroll.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

8

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas5

Consumer Services

Consumer Services

Consumer Non-Durables

Health Technology

Health Technology